Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SpeeDx (Molecular Diagnostic)

SpeeDx (Molecular Diagnostic)
2009 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
8 INVESTORS
Description

Provider of molecular diagnostics solutions intended to develop innovative multiplex systems for clinical diagnostics. The company uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • Suite G16, National Innovation Centre
  • Australian Technology Park, 4 Cornwallis Street, Eveleigh
  • Sydney, New South Wales 2015
  • Australia

+61 (02) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SpeeDx (Molecular Diagnostic)’s full profile, request a free trial.

SpeeDx (Molecular Diagnostic) Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 05-Aug-2019 $10M 0000 Completed Generating Revenue
7. Later Stage VC (Series A) 23-Apr-2019 000 000 Completed Generating Revenue
6. Grant 04-Sep-2017 00.000 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 01-Jul-2016 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
2. Grant 11-May-2014 $1.8M Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

SpeeDx (Molecular Diagnostic) Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Northpond Ventures Venture Capital Minority 000 0000 000000 0
Global Connections Fund Other 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator Minority 000 0000 000000 0
New South Wales Medical Device Fund Corporation 000 0000 000000 0
Cicada Innovations Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

SpeeDx (Molecular Diagnostic) Executive Team (5)

Name Title Board
Seat
Contact
Info
Colin Denver Chief Executive Officer
Bhavin Raval Chief Financial Officer
Elisa Mokany Ph.D Co-Founder & Chief Technology Officer
Alison Todd Ph.D Co-Founder & Chief Scientific Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

SpeeDx (Molecular Diagnostic) Board Members (4)

Name Representing Role Since Contact
Info
Andrew Denver Self Chairman 000 0000
Andrew Jane Self Board Member 000 0000
John Klopp SpeeDx (Molecular Diagnostic) Board Member 000 0000
Michael Rubin MD Northpond Ventures Board Member 000 0000